Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Quell Therapeutics Limited
Quell Therapeutics Limited is an active company incorporated on 19 March 2019 with the registered office located in London, Greater London. Quell Therapeutics Limited was registered 6 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
11890040
Private limited company
Age
6 years
Incorporated
19 March 2019
Size
Medium
Turnover is under
£54M
Under
250 employees
Confirmation
Submitted
Dated
28 April 2025
(8 months ago)
Next confirmation dated
28 April 2026
Due by
12 May 2026
(4 months remaining)
Last change occurred
7 months ago
Accounts
Submitted
For period
1 Jan
⟶
31 Dec 2024
(1 year)
Accounts type is
Full
Next accounts for period
31 December 2025
Due by
30 September 2026
(8 months remaining)
Learn more about Quell Therapeutics Limited
Contact
Update Details
Address
3rd Floor, Translation & Innovation Hub
84 Wood Lane
London
W12 0BZ
England
Same address for the past
5 years
Companies in W12 0BZ
Telephone
020 70969012
Email
Unreported
Website
Unreported
See All Contacts
People
Officers
9
Shareholders
93
Controllers (PSC)
1
Dame Catherine Elizabeth Bingham
Director • Venture Capitalist • British • Lives in UK • Born in Oct 1965
Jeffrey Stephen Long-McGie
Director • Financial Analyst • American • Lives in United States • Born in Feb 1976
Dr Elisa Michela Petris
Director • Investor • Italian,canadian • Lives in England • Born in Jan 1979
Luke Beshar
Director • Self Employed • American • Lives in United States • Born in May 1958
Sir Robert Lechler
Director • University Professor • British • Lives in UK • Born in Dec 1951
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
SV Health Investors UK Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Pulmocide Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Autifony Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Sitryx Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Enara Bio Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Alchemab Therapeutics Ltd
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Mestag Therapeutics Ltd
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Beacon Therapeutics Holdings Limited
Dr Elisa Michela Petris is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Dec 2024
For period
31 Dec
⟶
31 Dec 2024
Traded for
12 months
Cash in Bank
£60.47M
Decreased by £46.25M (-43%)
Turnover
£43.83M
Increased by £34.67M (+378%)
Employees
146
Increased by 8 (+6%)
Total Assets
£90.77M
Decreased by £36.78M (-29%)
Total Liabilities
-£12.18M
Decreased by £32.94M (-73%)
Net Assets
£78.59M
Decreased by £3.85M (-5%)
Debt Ratio (%)
13%
Decreased by 21.95% (-62%)
See 10 Year Full Financials
Latest Activity
Shares Cancelled
24 Days Ago on 15 Dec 2025
Own Shares Purchased
24 Days Ago on 15 Dec 2025
Own Shares Purchased
24 Days Ago on 15 Dec 2025
Shares Cancelled
1 Month Ago on 19 Nov 2025
Mr Luke Beshar Appointed
5 Months Ago on 24 Jul 2025
Full Accounts Submitted
5 Months Ago on 23 Jul 2025
Annette Clancy Appointed
6 Months Ago on 13 Jun 2025
Confirmation Submitted
7 Months Ago on 2 Jun 2025
Rachel Brooke Mears Resigned
7 Months Ago on 31 May 2025
Full Accounts Submitted
1 Year 2 Months Ago on 12 Oct 2024
Get Alerts
Get Credit Report
Discover Quell Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Cancellation of shares. Statement of capital on 31 October 2025
Submitted on 15 Dec 2025
Purchase of own shares.
Submitted on 15 Dec 2025
Purchase of own shares.
Submitted on 15 Dec 2025
Cancellation of shares. Statement of capital on 31 October 2025
Submitted on 19 Nov 2025
Change of share class name or designation
Submitted on 1 Oct 2025
Particulars of variation of rights attached to shares
Submitted on 30 Sep 2025
Second filing for the appointment of Mr Luke Beshar as a director
Submitted on 1 Sep 2025
Appointment of Mr Luke Beshar as a director on 24 July 2025
Submitted on 29 Aug 2025
Full accounts made up to 31 December 2024
Submitted on 23 Jul 2025
Appointment of Annette Clancy as a director on 13 June 2025
Submitted on 27 Jun 2025
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs